{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:42:31Z","timestamp":1784252551813,"version":"3.55.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan","award":["15K09135"],"award-info":[{"award-number":["15K09135"]}]},{"name":"Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan","award":["15H04673"],"award-info":[{"award-number":["15H04673"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182329","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T18:00:57Z","timestamp":1501783257000},"page":"e0182329","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6"],"prefix":"10.1371","volume":"12","author":[{"given":"Sei-ichiro","family":"Ohkura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1752-8082","authenticated-orcid":true,"given":"Soichiro","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Takuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotoshi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Takuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"issue":"18","key":"ref1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"D Levy","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"H1043","DOI":"10.1152\/ajpheart.00990.2002","article-title":"Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus","volume":"284","author":"C Morisco","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"J Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/biof.1030","article-title":"Sphingosine-1-phosphate signaling in physiology and diseases","volume":"38","author":"Y Takuwa","year":"2012","journal-title":"Biofactors"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.RES.85.11.1000","article-title":"Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes","volume":"85","author":"K Sekiguchi","year":"1999","journal-title":"Circ Res"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1006\/jmcc.2001.1433","article-title":"EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes","volume":"33","author":"P Robert","year":"2001","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"H1193","DOI":"10.1152\/ajpheart.01032.2008","article-title":"Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction","volume":"296","author":"CC Yeh","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp312","article-title":"S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species","volume":"85","author":"N Takuwa","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy","volume":"91","author":"I Manabe","year":"2002","journal-title":"Circ Res"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCRESAHA.110.231910","article-title":"Origins of cardiac fibroblasts","volume":"107","author":"EM Zeisberg","year":"2010","journal-title":"Circ Res"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cvr\/cvp086","article-title":"Sphingosine-1-phosphate receptor signalling in the heart","volume":"82","author":"CK Means","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1161\/CIRCRESAHA.112.271361","article-title":"From skeleton to cytoskeleton: osteocalcin transforms vascular fibroblasts to myofibroblasts via angiotensin II and Toll-like receptor 4","volume":"111","author":"CY Yuen","year":"2012","journal-title":"Circ Res"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/j.gastro.2009.07.006","article-title":"Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice","volume":"137","author":"R Higashiyama","year":"2009","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","article-title":"The cardiac fibroblast: therapeutic target in myocardial remodeling and failure","volume":"45","author":"RD Brown","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"T Moore-Morris","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2007.04.007","article-title":"Adult cardiac fibroblasts null for sphingosine kinase-1 exhibit growth dysregulation and an enhanced proinflammatory response","volume":"43","author":"R Kacimi","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"KE Porter","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","article-title":"Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload","volume":"120","author":"N Takeda","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.108.180976","article-title":"Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy","volume":"104","author":"F Jaffre","year":"2009","journal-title":"Circ Res"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1073\/pnas.92.11.4862","article-title":"Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice","volume":"92","author":"H Hirota","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"ref21","doi-asserted-by":"crossref","first-page":"29717","DOI":"10.1074\/jbc.M003128200","article-title":"Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes","volume":"275","author":"M Sano","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2353\/ajpath.2007.061078","article-title":"Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo","volume":"171","author":"B Coles","year":"2007","journal-title":"Am J Pathol"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2250","article-title":"STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors","volume":"16","author":"H Lee","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ccr.2012.11.013","article-title":"Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer","volume":"23","author":"J Liang","year":"2013","journal-title":"Cancer Cell"},{"issue":"6528","key":"ref25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/375247a0","article-title":"Direct stimulation of Jak\/STAT pathway by the angiotensin II AT1 receptor","volume":"375","author":"MB Marrero","year":"1995","journal-title":"Nature"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/HYPERTENSIONAHA.106.075085","article-title":"Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look","volume":"49","author":"TL Reudelhuber","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.HYP.31.6.1324","article-title":"Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system","volume":"31","author":"L Mazzolai","year":"1998","journal-title":"Hypertension"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","article-title":"Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death","volume":"165","author":"HD Xiao","year":"2004","journal-title":"Am J Pathol"},{"issue":"47","key":"ref29","doi-asserted-by":"crossref","first-page":"44012","DOI":"10.1074\/jbc.M106132200","article-title":"Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart","volume":"276","author":"JP van Kats","year":"2001","journal-title":"J Biol Chem"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"P Paradis","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"H2944","DOI":"10.1152\/ajpheart.01331.2006","article-title":"Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury","volume":"292","author":"CK Means","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:52:48Z","timestamp":1588999968000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182329"}},"subtitle":[],"editor":[{"given":"Junichi","family":"Sadoshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182329","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}